BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24133589)

  • 21. Spectrum of somatic EGFR, KRAS, BRAF, PTEN mutations and TTF-1 expression in Brazilian lung cancer patients.
    Carneiro JG; Couto PG; Bastos-Rodrigues L; Bicalho MA; Vidigal PV; Vilhena A; Amaral NF; Bale AE; Friedman E; De Marco L
    Genet Res (Camb); 2014; 96():e002. PubMed ID: 24594201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
    Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
    Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous thrombopoietin promotes non-small-cell lung carcinoma cell proliferation and migration by regulating EGFR signalling.
    Zou Z; Fan X; Liu Y; Sun Y; Zhang X; Sun G; Li X; Xu S
    J Cell Mol Med; 2020 Jun; 24(12):6644-6657. PubMed ID: 32337844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer.
    Zhao M; Xu P; Liu Z; Zhen Y; Chen Y; Liu Y; Fu Q; Deng X; Liang Z; Li Y; Lin X; Fang W
    Cell Death Dis; 2018 Jan; 9(2):78. PubMed ID: 29362431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of growth differentiation factor-15 inhibited nonsmall cell lung cancer through inactivating PTEN/PI3K/AKT signaling pathway.
    Liu Y; Lei J; Ji X; Li C; Chen X; Wang J; Dong J; Zhang H; Li Y
    Genes Genomics; 2023 Apr; 45(4):507-517. PubMed ID: 36306063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha.
    Phillips RJ; Mestas J; Gharaee-Kermani M; Burdick MD; Sica A; Belperio JA; Keane MP; Strieter RM
    J Biol Chem; 2005 Jun; 280(23):22473-81. PubMed ID: 15802268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
    De Marco C; Laudanna C; Rinaldo N; Oliveira DM; Ravo M; Weisz A; Ceccarelli M; Caira E; Rizzuto A; Zoppoli P; Malanga D; Viglietto G
    PLoS One; 2017; 12(6):e0178865. PubMed ID: 28662101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated Akt expression has significant correlation with EGFR and TGF-alpha expressions in stage I NSCLC.
    Mukohara T; Kudoh S; Matsuura K; Yamauchi S; Kimura T; Yoshimura N; Kanazawa H; Hirata K; Inoue K; Wanibuchi H; Fukushima S; Yoshikawa J
    Anticancer Res; 2004; 24(1):11-7. PubMed ID: 15015570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer.
    Yoshizawa A; Fukuoka J; Shimizu S; Shilo K; Franks TJ; Hewitt SM; Fujii T; Cordon-Cardo C; Jen J; Travis WD
    Clin Cancer Res; 2010 Jan; 16(1):240-8. PubMed ID: 20008839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of modulation through PI3K-AKT pathway about Nepeta cataria L.'s extract in non-small cell lung cancer.
    Fan J; Bao Y; Meng X; Wang S; Li T; Chang X; Yang G; Bo T
    Oncotarget; 2017 May; 8(19):31395-31405. PubMed ID: 28404902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of epidermal growth factor receptor (EGFR) and downstream-activated peptides in surgically excised non-small-cell lung cancer (NSCLC).
    Mukohara T; Kudoh S; Yamauchi S; Kimura T; Yoshimura N; Kanazawa H; Hirata K; Wanibuchi H; Fukushima S; Inoue K; Yoshikawa J
    Lung Cancer; 2003 Aug; 41(2):123-30. PubMed ID: 12871775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTEN and PI3K/AKT in non-small-cell lung cancer.
    Pérez-Ramírez C; Cañadas-Garre M; Molina MÁ; Faus-Dáder MJ; Calleja-Hernández MÁ
    Pharmacogenomics; 2015 Nov; 16(16):1843-62. PubMed ID: 26555006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non‑coding RNA FER1L4 inhibits cell proliferation and promotes cell apoptosis via the PTEN/AKT/p53 signaling pathway in lung cancer.
    Ouyang L; Yang M; Wang X; Fan J; Liu X; Zhang Y; Shu Y
    Oncol Rep; 2021 Jan; 45(1):359-367. PubMed ID: 33416121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relationship between PTEN expression and PI3K/AKT signal pathway in colon carcinoma].
    Qi JK; Huang XL; Meng ZM; Gan HT; Fu DG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):644-6, 654. PubMed ID: 19764563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis.
    Chen T; Liu Y; Li C; Xu C; Ding C; Chen J; Zhao J
    Cancer Treat Res Commun; 2021; 28():100412. PubMed ID: 34119765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-1297 Promotes Cell Proliferation of Non-Small Cell Lung Cancer Cells: Involving in PTEN/Akt/Skp2 Signaling Pathway.
    Bu W; Luo T
    DNA Cell Biol; 2017 Nov; 36(11):976-982. PubMed ID: 28872922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubiquitin-specific protease 44 inhibits cell growth by suppressing AKT signaling in non-small cell lung cancer.
    Zhang YK; Tian WZ; Zhang RS; Zhang YJ; Ma HT
    Kaohsiung J Med Sci; 2019 Sep; 35(9):535-541. PubMed ID: 31197957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTPIP51 inhibits non-small-cell lung cancer by promoting PTEN-mediated EGFR degradation.
    He M; Wang X; Chen W; Zhang J; Xiong Y; Cao L; Zhang L; Zhao N; Yang Y; Wang L
    Life Sci; 2022 May; 297():120293. PubMed ID: 35240162
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical characterization of the mTOR pathway in stage-I non-small-cell lung carcinoma.
    Shin E; Choi CM; Kim HR; Jang SJ; Park YS
    Lung Cancer; 2015 Jul; 89(1):13-8. PubMed ID: 25936472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.
    Shao G; Wang R; Sun A; Wei J; Peng K; Dai Q; Yang W; Lin Q
    Mol Cancer; 2018 Feb; 17(1):24. PubMed ID: 29455656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.